Why is this ASX 200 healthcare share jumping 7% today?

This healthcare share is getting a lot of love from investors today.

| More on:
Young doctor raising arms in air with hands in fists celebrating a new development

Image source: Getty Images

You’re reading a free article with opinions that may differ from The Motley Fool’s Premium Investing Services. Become a Motley Fool member today to get instant access to our top analyst recommendations, in-depth research, investing resources, and more. Learn More

The Ramsay Health Care Ltd (ASX: RHC) share price is having a strong session on Wednesday.

In morning trade, the ASX 200 healthcare share is up 7% to $58.68.

Why is this ASX 200 healthcare share racing higher?

Investors have been bidding Ramsay Health Care shares higher today after the private hospital operator released a couple of announcements.

The first announcement reveals that the company is looking to offload its 50% owned Ramsay Sime Darby Health Care (RSD) joint venture in Asia.

The release notes that the decision was made following the receipt of significant inbound interest in RSD at values that it feels are in shareholders' interests to explore. Though, it warns that there is no certainty that a sale process will result in a completed transaction.

Ramsay also revealed that the business continues to perform strongly, with its equity accounted contribution for the 9 months to 31 March 2023 up 31.7% to $16.2 million.

What else?

A second announcement reveals that the ASX 200 healthcare share has refinanced its bank loan facilities.

According to the release, the company has secured $1.5 billion in new committed revolving bank loan facilities with two of its key relationship banks.

The facilities, which will mature in FY 2026, are part of Ramsay Health Care's ongoing bank loan refinancing activities. They will be used to repay facilities maturing in FY 2025.

Management also advised that it will continue to seek to diversify the source and tenor of its borrowings over time.

While today's gain is of course good news for shareholders, it does not change much for them on a 12-month basis. Since this time last year, the ASX 200 healthcare share has lost almost 21% of its value.

Motley Fool contributor James Mickleboro has no position in any of the stocks mentioned. The Motley Fool Australia's parent company Motley Fool Holdings Inc. has no position in any of the stocks mentioned. The Motley Fool Australia has no position in any of the stocks mentioned. The Motley Fool has a disclosure policy. This article contains general investment advice only (under AFSL 400691). Authorised by Scott Phillips.

More on Healthcare Shares

woman testing substance in laboratory dish, csl share price
Share Market News

After a 73% surge this ASX healthcare share looks far from done

Brokers are upbeat, and some see possible gains of 90% in 2026.

Read more »

Female scientist working in a laboratory.
Healthcare Shares

Which biotech's shares are surging higher on US patent news?

Investors like what they see from this drug company.

Read more »

Medical workers examine an xray or scan in a hospital laboratory.
Healthcare Shares

This biotech company's shares are on a tear – again – after another contract win

A new contract with a prestigious US institution spells good news for shareholders.

Read more »

Child with superhero mask and cape flies after jumping on sofa
AI Stocks

3 of the fastest-growing stocks on the planet in 2025

These stocks soared in 2025.

Read more »

Shot of a mature scientists working on a laptop in a lab.
Healthcare Shares

Could CSL shares outperform the ASX 200 in 2026?

After shocking investors in 2025, CSL shares may be setting up for a comeback. Here’s why 2026 could look better.

Read more »

A man holds his head in his hands after seeing bad news on his laptop screen.
Healthcare Shares

Why did CSL shares crash 39% in 2025?

Should you be buying the dip? Let's find out.

Read more »

A group of people in a corporate setting do a collective high five.
Healthcare Shares

Why 4DMedical shares are jumping 14% today

4DMedical shares climb on a new CFO appointment as investors focus on US expansion and rising use of its lung…

Read more »

A business woman flexes her muscles overlooking a city scape below.
Healthcare Shares

Why I plan to buy this incredible ASX 200 stock in 2026

A 33% pullback has put Pro Medicus back in focus. Here’s why I’m preparing to buy its shares in 2026.

Read more »